NZ575354A - Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators - Google Patents

Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators

Info

Publication number
NZ575354A
NZ575354A NZ575354A NZ57535407A NZ575354A NZ 575354 A NZ575354 A NZ 575354A NZ 575354 A NZ575354 A NZ 575354A NZ 57535407 A NZ57535407 A NZ 57535407A NZ 575354 A NZ575354 A NZ 575354A
Authority
NZ
New Zealand
Prior art keywords
compound
phenyl
pain
pyridine
preferred
Prior art date
Application number
NZ575354A
Other languages
English (en)
Inventor
Bjarne H Dahl
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Priority claimed from PCT/EP2007/061433 external-priority patent/WO2008049864A1/en
Publication of NZ575354A publication Critical patent/NZ575354A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ575354A 2006-10-25 2007-10-24 Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators NZ575354A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200601380 2006-10-25
PCT/EP2007/061433 WO2008049864A1 (en) 2006-10-25 2007-10-24 Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators

Publications (1)

Publication Number Publication Date
NZ575354A true NZ575354A (en) 2012-05-25

Family

ID=40996458

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ575354A NZ575354A (en) 2006-10-25 2007-10-24 Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators

Country Status (7)

Country Link
KR (1) KR20090069183A (uk)
CN (1) CN101553486A (uk)
BR (1) BRPI0717306A2 (uk)
NZ (1) NZ575354A (uk)
RU (1) RU2009113451A (uk)
UA (1) UA99443C2 (uk)
ZA (1) ZA200901521B (uk)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG192939A1 (en) * 2011-02-25 2013-09-30 Janssen Pharmaceutica Nv PYRIDIN-4-YL)BENZYLAMIDES AS ALLOSTERIC MODULATORS OF ALPHA 7 nAChR
CN103420998A (zh) * 2012-05-16 2013-12-04 苏州爱斯鹏药物研发有限责任公司 一种新型噁二唑衍生物的合成方法
CN111362930B (zh) * 2020-04-15 2023-02-03 安徽医科大学 一种1，2，4-噁二唑-吡啶类化合物及其应用

Also Published As

Publication number Publication date
UA99443C2 (uk) 2012-08-27
ZA200901521B (en) 2010-06-30
CN101553486A (zh) 2009-10-07
KR20090069183A (ko) 2009-06-29
RU2009113451A (ru) 2010-11-27
BRPI0717306A2 (pt) 2014-04-15

Similar Documents

Publication Publication Date Title
US20100029685A1 (en) Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators
US8017631B2 (en) Oxadiazole derivatives and their medical use
CA2780218C (en) Morpholinothiazoles as alpha 7 positive allosteric modulators
US11180490B2 (en) Cyclopropyl urea formyl peptide 2 receptor and formyl peptide 1 receptor agonists
JP3295143B2 (ja) ベンズアニリド誘導体
JP2010507619A5 (uk)
JP2013517271A (ja) Ｃｂ２受容体を調節する化合物
JP2007519694A (ja) Ｐ３８キナーゼ阻害剤
JP6076498B2 (ja) ナンセンス突然変異抑制剤としてのピリミド［４，５−ｂ］キノリン−４，５（３ｈ，１０ｈ）−ジオン
JP2007522142A (ja) Ｉｋｋ３に対して活性を有するベンゾイミダゾール置換チオフェン誘導体
NZ590463A (en) Selected 1H-quinazoline-2,4-diones and their use as AMPA-receptor ligands
JP2013515032A (ja) 二置換ヘテロアリール縮合ピリジン類
JP2021528454A (ja) 化合物
CN113710656A (zh) 作为法尼醇x受体调节剂的经取代的双环化合物
JP2018138609A (ja) ナフチリジンジオン誘導体
EP3887366A1 (en) Pyrrolidinone derivatives as formyl peptide 2 receptor agonists
JP5057982B2 (ja) ヒスタミンｈ３受容体阻害剤、製造及び治療的使用
NZ575354A (en) Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators
JP3012338B2 (ja) アリールおよびヘテロアリールアルコキシナフタレン誘導体
JP2017516803A (ja) ナトリウムチャネル阻害剤として有用なベンゼンスルホンアミド
JP2000509044A (ja) ヘテロサイクリック化合物群
EA047337B1 (ru) Замещенные бициклические соединения в качестве модуляторов фарнезоидного х-рецептора

Legal Events

Date Code Title Description
PSEA Patent sealed
LAPS Patent lapsed